Contract Pharma Manufacturing Solutions

  1. Advancing Your Protein 5/5/2026

    Examine how a CMDO with extensive experience can deliver efficient and high-yielding custom protein manufacturing, supporting clients throughout the entire protein development process.

  2. End-To-End Advanced Therapy CDMO Services 9/21/2026

    A capabilities overview of advanced therapy CDMO services spanning viral vector, cell therapy, and mRNA development, manufacturing, cold chain logistics, and integrated program management across a global site network.

  3. U.S. Pharmaceutical Tariffs (Section 232): Implications & Actions 4/16/2026

    New U.S. tariffs are reshaping pharma manufacturing. Early action to assess exposure and pursue onshoring can cut risk, protect margins, and strengthen supply chains.

  4. Customized CMC Solutions

    Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.

  5. Improve The Performance Of Your Biologic Formulations 6/11/2026

    Advanced nanotechnology improves biologics with higher drug loads, better stability, new delivery routes, and enhanced performance in injectables, inhalation, and long‑acting therapies.

  6. Integrated Vector Production Capabilities 10/29/2019

    From products and services to complete manufacturing offerings, find out how MilliporeSigma can help you produce better, faster viral vectors.   

  7. Expanding Global API Manufacturing Capacity In Dalian 5/12/2026

    Growing capacity and advanced processes support small‑molecule programs from development through commercialization with reliable, scalable manufacturing.

  8. PNM Filters: Nylon 6,6 Membrane 6/22/2026

    Optimize sterile filtration with chemically compatible membranes to ensure consistent retention, strong flow, and scalable performance for aqueous and solvent-based solutions in high-purity applications.

  9. Bring Advanced ASD Tech Into Your Lab 3/13/2026

    A lab‑ready leasing program offers solvent‑free dispersion technology for rapid prototyping, broader formulation options, hands‑on development, and technical support—without capital investment.

  10. Fermentation Development And Manufacturing 5/19/2026

    Scale microbial fermentation from preclinical to 40,000 L GMP with integrated biocatalysis and downstream processing. Explore Curia's full capabilities.